These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 23429748)

  • 1. Neuroendocrine tumours: cracking the epigenetic code.
    Karpathakis A; Dibra H; Thirlwell C
    Endocr Relat Cancer; 2013 Jun; 20(3):R65-82. PubMed ID: 23429748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NETs: organ-related epigenetic derangements and potential clinical applications.
    Cives M; Simone V; Rizzo FM; Silvestris F
    Oncotarget; 2016 Aug; 7(35):57414-57429. PubMed ID: 27418145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic and epigenetic drivers of neuroendocrine tumours (NET).
    Di Domenico A; Wiedmer T; Marinoni I; Perren A
    Endocr Relat Cancer; 2017 Sep; 24(9):R315-R334. PubMed ID: 28710117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic changes in gastroenteropancreatic neuroendocrine tumours.
    Mapelli P; Aboagye EO; Stebbing J; Sharma R
    Oncogene; 2015 Aug; 34(34):4439-47. PubMed ID: 25435371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications.
    McMurry HS; Rivero JD; Chen EY; Kardosh A; Lopez CD; Pegna GJ
    Curr Probl Cancer; 2024 Oct; 52():101131. PubMed ID: 39173542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.
    Pipinikas CP; Berner AM; Sposito T; Thirlwell C
    Endocr Relat Cancer; 2019 Aug; 26(9):R519-R544. PubMed ID: 31252410
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic and epigenetic prognosticators of neuroendocrine tumours of the GI tract, liver, biliary tract and pancreas: A systematic review and meta-analysis.
    Mestre-Alagarda C; Srirajaskanthan R; Zen Y; Giwa M; Howard M; Ooft ML
    Histopathology; 2024 Jan; 84(2):255-265. PubMed ID: 37565289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids.
    Dreijerink KM; Derks JL; Cataldo I; Scarpa A; Valk GD; Speel EJ
    Front Horm Res; 2015; 44():115-38. PubMed ID: 26303708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics and epigenetics in small intestinal neuroendocrine tumours.
    Stålberg P; Westin G; Thirlwell C
    J Intern Med; 2016 Dec; 280(6):584-594. PubMed ID: 27306880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic regulation of SST
    Klomp MJ; Refardt J; van Koetsveld PM; Campana C; Dalm SU; Dogan F; van Velthuysen MF; Feelders RA; de Herder WW; Hofland J; Hofland LJ
    Front Endocrinol (Lausanne); 2023; 14():1184436. PubMed ID: 37223009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines.
    Boora GK; Kanwar R; Kulkarni AA; Pleticha J; Ames M; Schroth G; Beutler AS; Banck MS
    Cancer Genet; 2015; 208(7-8):374-81. PubMed ID: 26087898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
    Scarpa A
    Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastroenteropancreatic endocrine tumors.
    Meeker A; Heaphy C
    Mol Cell Endocrinol; 2014 Apr; 386(1-2):101-20. PubMed ID: 23906538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic aspects on therapy development for gastroenteropancreatic neuroendocrine tumors.
    Larsson C
    Neuroendocrinology; 2013; 97(1):19-25. PubMed ID: 22456267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent silencing of RASSF1A by DNA methylation in thymic neuroendocrine tumours.
    Kajiura K; Takizawa H; Morimoto Y; Masuda K; Tsuboi M; Kishibuchi R; Wusiman N; Sawada T; Kawakita N; Toba H; Yoshida M; Kawakami Y; Naruto T; Imoto I; Tangoku A; Kondo K
    Lung Cancer; 2017 Sep; 111():116-123. PubMed ID: 28838380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics of gastroenteropancreatic neuroendocrine tumors: A clinicopathologic perspective.
    Finnerty BM; Gray KD; Moore MD; Zarnegar R; Fahey Iii TJ
    World J Gastrointest Oncol; 2017 Sep; 9(9):341-353. PubMed ID: 28979716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Epigenetics of Neuroendocrine Tumors: The Road Ahead.
    Colao A; de Nigris F; Modica R; Napoli C
    Front Endocrinol (Lausanne); 2020; 11():604341. PubMed ID: 33384663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites.
    Pareja F; Vahdatinia M; Marchio C; Lee SSK; Da Cruz Paula A; Derakhshan F; da Silva EM; Selenica P; Dopeso H; Chandarlapaty S; Wen HY; Vincent-Salomon A; Brogi E; Weigelt B; Reis-Filho JS
    J Clin Pathol; 2022 Jan; 75(1):10-17. PubMed ID: 33148628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome Consortium.
    Mafficini A; Scarpa A
    J Endocrinol; 2018 Mar; 236(3):R161-R167. PubMed ID: 29321190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypo-methylation mediates chromosomal instability in pancreatic NET.
    Marinoni I; Wiederkeher A; Wiedmer T; Pantasis S; Di Domenico A; Frank R; Vassella E; Schmitt A; Perren A
    Endocr Relat Cancer; 2017 Mar; 24(3):137-146. PubMed ID: 28115389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.